학술논문
Therapeutic drug monitoring is more cost-effective than a clinically based approach in the management of loss of response to infliximab in inflammatory bowel disease: An observational multicentre study
Document Type
Article
Author
Source
In: Journal of Crohn's and Colitis . (Journal of Crohn's and Colitis, 29 August 2018, 12(9):1079-1088)
Subject
Language
English
ISSN
18764479
18739946
18739946